CIBM PET HUG-UNIGE Molecular Imaging Section
Kelly Ceyzériat is a post-doctoral researcher in the CIBM PET HUG-UNIGE Molecular Imaging section .
She obtained a master’s degree in integrative neuroscience from Pierre et Marie Curie University (Paris VI, France) in 2014. She then enrolled a PhD program at the University Paris-Saclay, in the molecular imaging center of the French Alternative Energies and Atomic Energy Commission (CEA, Fontenay-aux-Roses, France). During her PhD, she demonstrated, with new molecular tools based on viral vectors, that a signaling pathway is necessary and sufficient to astrocyte reactivity. Her work also underlined the importance and complexity of astrocyte functions in Alzheimer’s disease. She graduated as a PhD in neuroscience in December 2017. Since 2018, she is working as a post-doctoral researcher in the group of Prof Valentina Garibotto (Division of nuclear medicine and molecular imaging, HUG/CIBM PET HUG-UNIGE section). She manages a collaborative and translational project that aims at evaluating the therapeutic potential of low-dose radiation therapy for Alzheimer’s disease. In 2021, she shared her work time with the group of Prof Philippe Millet (Psychiatry department, HUG), on a project that aimed at better understanding the involvement of glial cells in the overexpression of TSPO (the 18kDa translocator protein), a marker of neuroinflammation, quantified by molecular imaging in rodents.
Her area of expertise includes in vivo imaging, animal behavior measurements and the use of multiple methodological approaches (stereotaxic surgery, histology, biochemistry, flow cytometry, transcriptomic…) to study Alzheimer’s disease progression and early markers.
KEYWORDS: Molecular imaging, positron emission tomography (PET), single photon emission computed tomography (SPECT), neurodegenerative diseases, neuroinflammation, neurosciences